Early promise from therapy targeting FGFR mutations
- This topic has 0 replies, 1 voice, and was last updated 10 years, 3 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Early promise from therapy targeting FGFR mutations.
“Anticancer activity was also seen for other patients with squamous cell lung carcinoma, squamous cell head and neck cancer, breast cancer, and cholangiocarcinoma.”
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.